Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2019 | 2016
Number of items: 3.

2019

McLaughlin, Vallerie V., Vachiery, Jean-Luc, Oudiz, Ronald J., Rosenkranz, Stephan, Galie, Nazzareno, Barbera, Joan A., Frost, Adaani E., Ghofrani, Hossein-Ardeschir, Peacock, Andrew J., Simonneau, Gerald, Rubin, Lewis J., Blair, Christiana, Langley, Jonathan and Hoeper, Marius M. (2019). Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial. J. Heart Lung Transplant., 38 (12). S. 1286 - 1296. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1557-3117

White, R. James, Vonk-Noordegraaf, Anton, Rosenkranz, Stephan, Oudiz, Ronald J., McLaughlin, Vallerie V., Hoeper, Marius M., Gruenig, Ekkehard, Ghofrani, Hossein-Ardeschir, Chakinala, Murali M., Barbera, Joan A., Blair, Christiana, Langley, Jonathan and Frost, Adaani E. (2019). Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension. Respir. Res., 20 (1). LONDON: BMC. ISSN 1465-993X

2016

Hoeper, Marius M., McLaughlin, Vallerie V., Albert Barbera, Joan, Frost, Adaani E., Ghofrani, Hossein-Ardeschir, Peacock, Andrew J., Simonneau, Gerald, Rosenkranz, Stephan, Oudiz, Ronald J., White, R. James, Miller, Karen L., Langley, Jonathan, Harris, Julia H. N., Blair, Christiana, Rubin, Lewis J. and Vachiery, Jean-Luc (2016). Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study. Lancet Resp. Med., 4 (11). S. 894 - 902. OXFORD: ELSEVIER SCI LTD. ISSN 2213-2600

This list was generated on Sat Apr 20 09:27:18 2024 CEST.